AC Immune SA
ACIU54
$3.690.00%$0.00
Penny Stock
ACIU54
$3.69
0.00%Performance History
| Key Stats | |
|---|---|
| Open | $3.75 |
| Prev. Close | $3.69 |
| EPS | -0.76 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $365.08M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 3.64 | 3.75 |
| 52 Week Range | 2.20 | 5.14 |
| Ratios | |
|---|---|
| EPS | -0.76 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About AC Immune SA (ACIU)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Andrea Pfeifer Ph.D.
- Headquarters
- Lausanne
- Employees
- 126
- Exchange
- NASDAQ
Keep an eye on AC Immune SA
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is AC Immune SA's (ACIU) price per share?
The current price per share for AC Immune SA (ACIU) is $3.69. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for AC Immune SA (ACIU)?
For AC Immune SA (ACIU), the 52-week high is $5.14, which is 39.3% from the current price. The 52-week low is $2.2, the current price is 67.73% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is AC Immune SA (ACIU) a growth stock?
AC Immune SA (ACIU) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AC Immune SA as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is AC Immune SA (ACIU) stock price performance year to date (YTD)?
As of the latest data, AC Immune SA (ACIU) has a year-to-date price change of -21.32%. Over the past month, the stock has experienced a price change of 9.17%. Over the last three months, the change has been -9.78%. Over the past six months, the figure is 13.36%. Looking at a longer horizon, the five-year price change stands at -31.54%.
help
Is AC Immune SA (ACIU) a profitable company?
AC Immune SA (ACIU) has a net income of -$54.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -3.05K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.8M, although specific revenue growth data is currently not available. Operating income is noted at -$53.62M. Furthermore, the EBITDA is -$68.74M.
help
What is the market capitalization of AC Immune SA (ACIU)?
AC Immune SA (ACIU) has a market capitalization of $365.09M. The average daily trading volume is 96.8K, indicating the stock's liquidity and investor engagement.
News
6/14/2024
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
6/13/2024
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
6/12/2024
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
CALENDAR OF EVENTS
5/28/2024AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
INTERIM INFORMATION
EARNINGS RELEASES AND OPERATING RESULTS
5/13/2024AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
LICENSING AGREEMENTS
BUSINESS CONTRACTS
5/13/2024AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease